1. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo
   Marija Nešović et al, 2020, Cancers CrossRef
2. RTK Inhibitors in Melanoma: From Bench to Bedside
   Malak Sabbah et al, 2021, Cancers CrossRef
3. Bosutinib, an SRC inhibitor, induces caspase‐independent cell death associated with permeabilization of lysosomal membranes in melanoma cells
   S. Noguchi et al, 2018, Veterinary and Comparative Oncology CrossRef
4. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607)
   Kevin Kalinsky et al, 2017, Cancer CrossRef
5. Anoikis patterns via machine learning strategy and experimental verification exhibit distinct prognostic and immune landscapes in melanoma
   Jinfang Liu et al, 2023, Clinical and Translational Oncology CrossRef
6. Anti‐growth and pro‐apoptotic effects of dasatinib on human oral cancer cells through multi‐targeted mechanisms
   Nam‐Sook Park et al, 2021, Journal of Cellular and Molecular Medicine CrossRef